TCRX vs VTRS · rev $2.0M vs rev $7.27B
Tscan Therapeutics Inc (TCRX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
TCRX currently screens at market cap $62.1M. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the TCRX and VTRS stock pages for the full models.
Not investment advice.